Efficacy of nefazodone in the treatment of depression

Journal of Psychopharmacology

Volumn 10, Issue SUPPL. 1, 1996, Pages 5-10

  Montgomery, S A ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Depression; Efficacy; Long term treatment; Nefazodone

Indexed keywords

FLUOXETINE; IMIPRAMINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; HUMAN; MAJOR DEPRESSION; MELANCHOLIA; PRIORITY JOURNAL; SLEEP DISORDER;

EID: 0029974310     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Anton S F, Robinson D S, Roberts D L, Kensler T T, English P A, Archibald D G (1994) Long-term treatment of depression with nefazodone. Psychopharmacol Bull 30: 165-169
2. Commission of the European Communities (1989) The rules governing medicinal products in the European Community. Volume III. Guidelines on the quality, safety and efficacy of medicinal products for human use. Luxembourg Office for Official Publications of the European Communities, pp. 209-218
3. Derogatis L R, Lipman R S, Rickels K, Uhlenhuth E H, Covi L (1974) Hopkins Symptom Check List (HSCL): a self report symptom inventory. Behav Sci 19: 1-15
4. Fawcett J A, Marcus R M, Anton S F, O'Brien K, Schwiderski U (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatr 56 (Suppl 6): 37-42
5. Feighner J P, Pambstkian R, Fowler R C, Boyer W F, D'Amico M F (1989) A comparison of nefazodone, imipramine, and placebo in patients with moderate to severe depression. Psychopharmacol Bull 25: 219-221
6. Fontaine R, Ontiveros A, Elie R (1994) A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatr 55: 234-241
7. Gammans R E, Roberts D L, Archibald D G et al. (1994) Efficacy of nefazodone in the long-term treatment of depression. In Lapierre Y D (ed.), Nefazodone: clinical impact of a unique dual mechanism of action, pp. 16-18
8. Guy W (1976) ECDEU assessment manual for psychopharmacology. US Department of Health, Education and Welfare publication ADM 76-338. National Institute of Mental Health, Rockville, MD
9. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychiatr 32: 50-55
10. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatr 33: 56-62
11. Mendels J, Reimherr F, Marcus R N, Roberts D L, Francis R J, Anton S F (1995) A double-blind placebo-controlled trial of two ranges of nefazodone in the treatment of depressed outpatients. J Clin Psychiatr 56 (Suppl 6): 30-36
12. Montgomery S A, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134: 382-389
13. Rickels K, Schweizer E, Clary C, Fox I,Weise C (1994) Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatr 164: 802-805
14. Schwiderski U, O'Brien K, Copp J, Gammans R, Marcus R, Robinson D (1992) Nefazodone efficacy in melancholic or recurrent depression. Presented at Collegium Internationale NeuroPsychopharmacologia (CINP), June 28-July 2